Canine Lymphoma

59 Canine Lymphoma






3. How is canine lymphoma classified and staged?

Canine lymphoma can be classified by anatomic site, histologic or cytologic phenotype, and immunophenotype. Clinical stage can be established based on the World Health Organization (WHO) clinical staging guidelines for domestic animals with lymphoma.


The four anatomic classification sites include the following:






More than 80% of canine lymphoma cases will be multicentric in nature. Mediastinal lymphoma is the least commonly seen form of canine lymphoma.


There are many histologic and cytologic grading schemes that can be used (e.g., Kiel, National Cancer Institute Working Foundation) to grade canine lymphomas based on tumor architecture, mitotic index, and cellular features. Regardless of which scheme is used, most canine lymphomas correlate to medium and high-grade non-Hodgkin’s lymphomas in human beings.


Immunophenotyping of canine lymphomas is used to determine whether the tumor is of Bor T-cell origin. Approximately 70% to 80% of canine lymphomas are of B-cell origin. Approximately 20% to 30% are of T-cell origin, and rarely are non-B, non-T cell tumors identified.


The WHO clinical staging for domestic animals with lymphoma guidelines are as follows:





< div class='tao-gold-member'>

Stay updated, free articles. Join our Telegram channel

Jul 31, 2016 | Posted by in INTERNAL MEDICINE | Comments Off on Canine Lymphoma

Full access? Get Clinical Tree

Get Clinical Tree app for offline access